CD38: From Positive to Negative Expression After Daratumumab Treatment

Cureus
doi 10.7759/cureus.7627
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cureus, Inc.

Related search

Daratumumab Induces CD38 Internalization and Impairs Myeloma Cell Adhesion

OncoImmunology
OncologyAllergyImmunology
2018English

The Therapeutic Human CD38 Antibody Daratumumab Improves the Anti-Myeloma Effect of Newly Emerging Multi-Drug Therapies

Blood Cancer Journal
OncologyHematology
2011English

Positive and Negative Effects of Anger Expression in Workplace

Korean Journal of Industrial and Organizational Psychology
2018English

Three Cases of Changed Reaction to Tuberculin From Positive to Negative

BMJ
1926English

Refractory Post‐Allogeneic Stem Cell Transplant Pure Red Cell Aplasia in Remission After Treatment With Daratumumab

American Journal of Hematology
Hematology
2019English

Differential Sensitivity to Learning From Positive and Negative Outcomes in Cocaine Users

Drug and Alcohol Dependence
PsychiatryToxicologyMental HealthPharmacology
2016English

Time to Be Positive About Negative Data?

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2017English

Positive and Negative Behaviours Resulting From Brand Attachment

European Journal of Marketing
Marketing
2018English

Surface Expression of Notch1 on Thymocytes: Correlation With the Double-Negative to Double-Positive Transition

Journal of Immunology
AllergyImmunology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy